Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aczone Maintenance in Acne Vulgaris
NCT01885910Phase 4Completed
- Sponsor
- DermResearch
- Start
- Jul 2013
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dapsone in acne vulgaris, sponsored by DermResearch. Primary endpoint: Percentage of Participants Who Remained Responders at Week 24. Started Jul 2013; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01885910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01885910.